Cargando…
Neuropsychotherapeutics /
Neuropsychotherapeutics, Volume 86, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field, with this updated edition including sections on Pharmacotherapy of psychiatric disorders, Allosteric mechanisms for neuropsychopharmacology...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam, The Netherlands :
Elsevier Academic Press,
2019.
|
| Edición: | First edition. |
| Colección: | Advances in pharmacology (San Diego, Calif.) ;
86. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_on1111636855 | ||
| 003 | OCoLC | ||
| 005 | 20231120010407.0 | ||
| 006 | m o d | ||
| 007 | cr mn|---auuua | ||
| 008 | 190802s2019 ne a ob 000 0 eng | ||
| 040 | |a AU@ |b eng |e rda |e pn |c AU@ |d OPELS |d OCLCF |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
| 020 | |z 9780128166680 |q (print) | ||
| 035 | |a (OCoLC)1111636855 | ||
| 050 | 4 | |a RM315 | |
| 082 | 0 | 4 | |a 615.7/8 |2 23 |
| 245 | 0 | 0 | |a Neuropsychotherapeutics / |c edited by Jeffrey M. Witkin. |
| 250 | |a First edition. | ||
| 264 | 1 | |a Amsterdam, The Netherlands : |b Elsevier Academic Press, |c 2019. | |
| 264 | 4 | |c �2019 | |
| 300 | |a 1 online resource (312 pages) : |b chiefly colour illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Advances in pharmacology, |x 1054-3589 ; |v v. 86 | |
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a Preface / Jeffrey M. Witkin -- GPCR drug discovery-moving beyond the orthosteric to the allosteric domain / Christian C. Felder -- Lipid rafts in psychiatry / Nathan H. Wray and Mark M. Rasenick -- Rapid-acting antidepressants / Jeffrey M. Witkin, Anna E. Martin, Lalit K. Golani, Nina Z. Xu and Jodi L. Smith -- mGlu2/3 receptor antagonists / Shigeyuki Chaki -- Nitric oxide: antidepressant mechanisms and inflammation / Mehdi Ghasemi -- Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders / Laura B. Teal, Robert W. Gould, Andrew S. Felts and Carrie K. Jones -- Medications development for food-based and drug use disorders / Fernando B. de Moura, Stephen J. Kohut and Jack Bergman -- Obsessive compulsive disorder (OCD): current treatments and a framework for neurotherapeutic research / Erik Z. Woody, Kurt Leroy Hoffman and Henry Szechtman -- Positive allosteric modulators of the dopamine D1 receptor: a new mechanism for the treatment of neuropsychiatric disorders / Kjell A. Svensson, Junliang Hao and Robert F. Bruns. | |
| 520 | |a Neuropsychotherapeutics, Volume 86, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field, with this updated edition including sections on Pharmacotherapy of psychiatric disorders, Allosteric mechanisms for neuropsychopharmacology, Lipid rafts, Rapid-acting antidepressants, mGlu2/3 receptor antagonists, Nitric oxide: antidepressant mechanisms and inflammation, Anxiety disorders, mGlu receptors and schizophrenia, mAChR ligands for schizophrenia and addiction, PDE10 inhibitors, Obsessive-compulsive disorder, Addiction disorders (including eating), Dopamine D1 PAMs as a New Mode for Treatment of Neuropsychiatric Disorders, and more. | ||
| 650 | 0 | |a Neuropsychopharmacology. | |
| 650 | 6 | |a Neuropsychopharmacologie. |0 (CaQQLa)201-0006772 | |
| 650 | 7 | |a Neuropsychopharmacology |2 fast |0 (OCoLC)fst01036504 | |
| 700 | 1 | |a Witkin, Jeffrey M., |e editor. | |
| 830 | 0 | |a Advances in pharmacology (San Diego, Calif.) ; |v 86. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/10543589/86 |z Texto completo |